Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Aeroscena Launches Groundbreaking Ascents® Gels Clinical Aromatherapy System; Believes Scent Should Heal, Not Harm
  • USA - English


News provided by

Aeroscena LLC

Dec 08, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Cleveland, OH (PRWEB) December 08, 2014 -- As the global leader in clinical aromatherapy, Aeroscena® understands the importance of creating environments that enhance well-being, rather than detracting from it. Therefore it should come as no surprise that Aeroscena® has released the next generation of groundbreaking, therapeutic aromatherapy products: 100% natural, allergen-free Ascents® Gels (http://www.shopascents.com/collections/the-ascents-gels-collection).

Science continues to prove that scent has the power to positively affect many different aspects of wellness, from mood to blood pressure to memory. Aeroscena® is and always will be at the forefront of important clinical aromatherapy research as it pertains to better health, utilizing our 100% natural essential oil formulas.

Unfortunately, many products on the market, from room fresheners to perfumes, do not fall into the same category as Ascents®'s products (http://www.shopascents.com) do in terms of safety, quality, efficacy or purity. In fact, most of these products, which are almost always manufactured from synthetic chemicals, appear do more harm than good, according to research from a number of different well-respected individuals and organizations:

-- According to the Environmental Working Group, many fragrances are manufactured using chemicals “with troubling hazardous properties or with a propensity to accumulate in human tissues.”

-- About 1 in 10 people are estimated to have ongoing allergic reactions to chemical elements in fragrances, and these allergies are on the rise with 55 percent of Americans testing positive for at least one allergen.

-- Two percent of the population are not just allergic, but completely chemically intolerant. This heightened chemical sensitivity can be incapacitating in the most extreme cases. Chemically intolerant people are also more likely to experience panic attacks or develop major depressive disorder, according to a recent study conducted at two Texas family medicine practices.

-- Experts such as Charity Asthma UK have warned that products such as plug-in deodorizers and air fresheners contain synthetic chemicals that could trigger asthma attacks.

-- Dr Stanley Fineman, of the Atlanta Allergy and Asthma Clinic, says those with asthma are especially sensitive to chemical fragrances due to a change in lung function that occurs during exposure.

Unlike synthetic fragrance oils used in many so-called “aromatherapy” systems, Ascents® Gels (http://www.shopascents.com/collections/the-ascents-gels-collection) are formulated with only 100% natural, therapeutic-grade essential oils. They are the latest advance in clinical aromatherapy; there is truly no other pure essential oil solid gel on the market that performs like Ascents® Gels do. Using absolutely no synthetic chemicals, Aeroscena® has instead opted for botanical essences that work in harmony with natural body chemistry to elicit beneficial, clinically-backed results.

Ascents® Gels (http://www.shopascents.com/collections/the-ascents-gels-collection) are available in four different therapeutic scents :

-- Calm No. 34: To alleviate stress and and anxiety

-- Sleep No. 91: For relief of insomnia and restlessness

-- Focus No. 04: For increased concentration and mental acuity

-- Energize No. 17: To revitalize and refresh

When used in concert with our best-selling ScentCube (http://www.shopascents.com/products/scentcube) ambient aromatherapy diffuser, Ascents® Gels yield a clean, hygienic, cold diffusion that produces no oil, smoke or ozone. They require no water for activation, last up to 30 days, and are suitable for use in home or commercial environments, including medical and dental clinics.

For more information about or to purchase the Ascents® clinical aromatherapy system, visit http://www.shopascents.com.

Founded in 2010, Aeroscena®'s mission is to give individuals control over their own well-being using 100% natural, clinically-backed aromatherapy solutions. Our products are recommended by doctors, used by hospitals™. Aeroscena® LLC is a privately held company headquartered in Cleveland, OH.

Mark Kohoot, Aeroscena LLC, http://www.shopascents.com, +1 (937) 551-1890, [email protected]

Modal title

Calm No. 34 Ascents® Gel
Calm No. 34 Ascents® Gel
Sleep No. 91 Ascents® Gel
Sleep No. 91 Ascents® Gel
Focus No. 04 Ascents® Gel
Focus No. 04 Ascents® Gel
Energize No. 17 Ascents® Gel
Energize No. 17 Ascents® Gel
ScentCube™
ScentCube™
Calm No. 34 Ascents® Gel Sleep No. 91 Ascents® Gel Focus No. 04 Ascents® Gel Energize No. 17 Ascents® Gel ScentCube™

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.